Superior Effectiveness of Zidovudine Compared With Tenofovir When Combined With Nevirapine-based Antiretroviral Therapy in a Large Nigerian Cohort.

导出 OA

翻译打印收藏纠错

作者： Kimberly K,Scarsi ^[1] ; Geoffrey,Eisen ^[2] ; Kristin M,Darin ^[2] ; Seema T,Meloni ^[3] ; Holly E,Rawizza ^[4] ; Eric J,Tchetgen Tchetgen ^[5] ; Oche O,Agbaji ^[6] ; Daniel I,Onwujekwe ^[7] ; Wadzani,Gashau ^[8] ; Reuben,Nkado ^[9] ; Prosper,Okonkwo ^[10] ; Robert L,Murphy ^[2] ; Phyllis J,Kanki ^[3] ; Harvard/APIN PEPFAR Team

作者单位： Department of Pharmacy Practice, University of Nebraska Medical Center, Omaha. ^[1] Center for Global Health, Northwestern University Feinberg School of Medicine, Chicago, Illinois. ^[2] Department of Immunology and Infectious Diseases, Harvard T. H. Chan School of Public Health. ^[3] Department of Immunology and Infectious Diseases, Harvard T. H. Chan School of Public Health Department of Medicine, Division of Infectious Diseases, Brigham and Women's Hospital. ^[4] Departments of Biostatistics and Epidemiology, Harvard T. H. Chan School of Public Health, Boston, Massachusetts. ^[5] Department of Medicine, University of Jos and Jos University Teaching Hospital. ^[6] Clinical Sciences Division, Nigerian Institute of Medical Research, Yaba. ^[7] Department of Medicine, University of Maiduguri Teaching Hospital. ^[8] Department of Medicine, 68 Military Hospital, Yaba (formerly, at the time of this work). ^[9] AIDS Prevention Initiative Nigeria, Ltd./Gte., Abuja, Nigeria. ^[10]

关键词 antiretroviral therapy nevirapine tenofovir virologic failure zidovudine